Feature | February 22, 2013

ACR Dose Index Registry Surpasses Five Million Scans

Data will help establish national benchmarks for CT dose indices

February 22, 2013 — Since its launch, less than two years ago, more than 5 million computed tomography (CT) scans, and nearly 3 million exams, have been added to the American College of Radiology (ACR) Dose Index Registry (DIR) — bringing the ACR closer to establishing national benchmarks for CT dose indices, which will help ensure patients receive safe, quality imaging care.

The DIR is a radiology data registry that provides standardized, size-adjusted CT dose indices that facilitate meaningful comparisons — allowing imaging facilities to compare their CT dose indices to regional and national values. Information related to dose indices for all CT exams is collected, anonymized, transmitted to the ACR and stored in a database. Institutions are then provided with periodic feedback reports comparing their results by body part and exam type to aggregate results. A sample report containing actual aggregated data from a participating facility is available here: http://bit.ly/127WGpk.

Currently, the DIR has over 600 registered facilities, including private practices, hospital-based facilities and academic centers. Participation in the DIR is voluntary and will help radiologists meet the requirements for a Physician Quality Reporting System registry starting in 2014.

“As our early success demonstrates, patient safety and CT dose optimization is of utmost importance to radiology professionals, including radiologists, medical physicists and radiologic technologists. As we get closer to establishing national benchmarks for CT dose indices, I hope more imaging facilities will consider participating in the DIR. Having the ability to track dose reduction efforts over time and ultimately lower the radiation dose that Americans receive from medical imaging scans is invaluable,” said Richard Morin, Ph.D., chair of the ACR Dose Index Registry.  

The DIR is part of the overall ACR approach to medical radiation reduction, which includes mandatory accreditation of all medical imaging providers and greater adoption of computerized decision support/imaging ordering systems based on ACR appropriateness criteria.

For additional information about the ACR Dose Index Registry: http://bit.ly/VPNTXm


Related Content

News | Cardiovascular Clinical Studies

Nov. 10, 2025 —Genomics, a science-led techbio company, has today announced new research that suggests polygenic risk ...

Home November 12, 2025
Home
News | Cardiovascular Clinical Studies

Oct. 21, 2025 – AskBio Inc., a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG ...

Home October 21, 2025
Home
News | Cardiovascular Clinical Studies

Aug. 25, 2025 — Merck, known as MSD outside of the United States and Canada, has announced that new clinical trial and ...

Home August 25, 2025
Home
News | Cardiovascular Clinical Studies

Aug. 18, 2025 — (Newswise) It’s often mistaken for a heart attack, but Takotsubo cardiomyopathy — previously known as ...

Home August 21, 2025
Home
News | Cardiovascular Clinical Studies

Aug. 20, 2025 — A major international study published in Atherosclerosis* has found that routinely testing for ...

Home August 20, 2025
Home
News | Cardiovascular Clinical Studies

Aug. 4, 2025 — Marea Therapeutics, Inc., a clinical-stage biotechnology company that develops next-generation medicines ...

Home August 04, 2025
Home
News | Cardiovascular Clinical Studies

July 16, 2025 — Medtronic has announced that the first patient has been enrolled in the PEripheral Onyx Liquid Embolic ...

Home July 22, 2025
Home
News | Cardiovascular Clinical Studies

June 11, 2025 — Bayer and the Broad Institute have have extended their research collaboration of 10 years by an ...

Home June 11, 2025
Home
News | Cardiovascular Clinical Studies

May 27, 2025 — Despite scientific advances in cardiovascular care, people in living in rural areas and other communities ...

Home May 27, 2025
Home
News | Cardiovascular Clinical Studies

May 20, 2025 — Shockwave Medical, Inc., part of Johnson & Johnson MedTechhas announced the 30-day primary endpoint ...

Home May 21, 2025
Home
Subscribe Now